Good morning :)
Place Order
Add to Watchlist

Amerise Biosciences Ltd

AMERISE Share Price

0.791.25% (-0.01)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹5 cr, stock is ranked 4,853

Stock is 3.61x as volatile as Nifty

AMERISE Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Low

Profitability and efficiency haven't been upto the mark

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

With a market cap of ₹5 cr, stock is ranked 4,853

Stock is 3.61x as volatile as Nifty

AMERISE Performance & Key Metrics

AMERISE Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
0.97
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
27.933.471.60%

AMERISE Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

AMERISE Company Profile

Amerise Biosciences Ltd is currently inactive and did not generate any revenue.

AMERISE Similar Stocks (Peers)

Compare with peers Compare with peers 

AMERISE Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
88.08
88.08
1Y Return
2.41%
2.41%
Buy Reco %
50.00
50.00
PE Ratio
42.09
42.09
1Y Return
2.63%
2.63%
Buy Reco %
92.31
92.31
PE Ratio
48.02
48.02
1Y Return
11.76%
11.76%
Buy Reco %
78.57
78.57
PE Ratio
28.77
28.77
1Y Return
65.60%
65.60%
Buy Reco %
0.00
0.00
PE Ratio
50.46
50.46
1Y Return
21.08%
21.08%
Buy Reco %
0.00
0.00
Compare with Peers

AMERISE Forecast

AMERISE Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

AMERISE

AMERISE

Income

Balance Sheet

Cash Flow

AMERISE Income Statement

AMERISE Income Statement

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue0.000.001.180.009.580.010.040.190.19
Raw Materialssubtract0.180.19
Power & Fuel Costsubtract
Employee Costsubtract0.010.010.010.040.040.050.020.07
Selling & Administrative Expensessubtract
Operating & Other expensessubtract0.930.011.160.110.138.970.110.11
Depreciation/Amortizationsubtract0.000.000.000.000.000.000.000.000.00
Interest & Other Itemssubtract
Taxes & Other Itemssubtract0.000.000.000.000.000.000.000.000.00
EPS-0.14-0.000.00-0.02-0.030.08-0.02-0.020.000.00
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.00

AMERISE Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

AMERISE Stock Peers

AMERISE Past Performance & Peer Comparison

AMERISE Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsWood Products

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Amerise Biosciences Ltd521.950.97
Century Plyboards (India) Ltd88.087.400.14%
Greenply Industries Ltd42.095.430.16%
Greenpanel Industries Ltd48.022.630.11%

AMERISE Stock Price Comparison

Compare AMERISE with any stock or ETF
Compare AMERISE with any stock or ETF
AMERISE
Loading...

AMERISE Holdings

AMERISE Shareholdings

AMERISE Promoter Holdings Trend

AMERISE Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

AMERISE Institutional Holdings Trend

AMERISE Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

AMERISE Shareholding Pattern

AMERISE Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding0.00%0.00%0.00%0.00%100.00%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

AMERISE Shareholding History

AMERISE Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

AMERISE Insider Trades & Bulk Stock Deals

AMERISE Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing AMERISE stock

smallcases containing AMERISE stock

Looks like this stock is not in any smallcase yet.

AMERISE Events

AMERISE Events

AMERISE Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AMERISE has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

AMERISE Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AMERISE has not given any dividends in last 5 years

AMERISE Dividends

AMERISE Dividends

Hmm, looks like data is unavailable here. Please come back after some time

AMERISE Stock News & Opinions

AMERISE Stock News & Opinions

Earnings
Amerise Biosciences standalone net profit rises 450.00% in the March 2025 quarter

Net profit of Amerise Biosciences rose 450.00% to Rs 0.11 crore in the quarter ended March 2025 as against Rs 0.02 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net profit reported to Rs 0.01 crore in the year ended March 2025 as against net loss of Rs 0.15 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Amerise Biosciences to hold board meeting

Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 19 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Amerise Biosciences reports standalone net loss of Rs 0.02 crore in the December 2024 quarter

Net Loss of Amerise Biosciences reported to Rs 0.02 crore in the quarter ended December 2024 as against net loss of Rs 0.06 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Amerise Biosciences schedules board meeting

Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 3 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Amerise Biosciences reports standalone net loss of Rs 0.03 crore in the September 2024 quarter

Net Loss of Amerise Biosciences reported to Rs 0.03 crore in the quarter ended September 2024 as against net loss of Rs 0.04 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Amerise Biosciences schedules board meeting

Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 22 October 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Amerise Biosciences schedules AGM

Amerise Biosciences announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
Amerise Biosciences reports standalone net loss of Rs 0.05 crore in the June 2024 quarter

Net Loss of Amerise Biosciences reported to Rs 0.05 crore in the quarter ended June 2024 as against net loss of Rs 0.07 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live

11 months agoCapital Market - Live
Corporate
Amerise Biosciences to table results

Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

Amradeep Industries renames as ‘Amerise Biosciences’

3 years agoIndia Infoline

Frequently asked questions

Frequently asked questions

  1. What is the share price of Amerise Biosciences Ltd (AMERISE) today?

    The share price of AMERISE as on 10th July 2025 is ₹0.79. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Amerise Biosciences Ltd (AMERISE) share?

    The past returns of Amerise Biosciences Ltd (AMERISE) share are
    • Past 1 week: -4.76%
    • Past 1 month: -8.05%
    • Past 3 months: -11.24%
    • Past 6 months: -31.90%
    • Past 1 year: 6.76%
    • Past 3 years: -23.30%
    • Past 5 years: -10.23%

  3. What are the peers or stocks similar to Amerise Biosciences Ltd (AMERISE)?
  4. What is the market cap of Amerise Biosciences Ltd (AMERISE) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Amerise Biosciences Ltd (AMERISE) is ₹5.22 Cr as of 10th July 2025.

  5. What is the 52 week high and low of Amerise Biosciences Ltd (AMERISE) share?

    The 52-week high of Amerise Biosciences Ltd (AMERISE) is ₹1.45 and the 52-week low is ₹0.62.

  6. What is the PE and PB ratio of Amerise Biosciences Ltd (AMERISE) stock?

    The P/E (price-to-earnings) ratio of Amerise Biosciences Ltd (AMERISE) is 521.95. The P/B (price-to-book) ratio is 0.97.

  7. Which sector does Amerise Biosciences Ltd (AMERISE) belong to?

    Amerise Biosciences Ltd (AMERISE) belongs to the Materials sector & Wood Products sub-sector.

  8. How to buy Amerise Biosciences Ltd (AMERISE) shares?

    You can directly buy Amerise Biosciences Ltd (AMERISE) shares on Tickertape. Simply sign up, connect your demat account and place your order.